Pharmacology of antifungal drugs (Fitz) Flashcards
Amphotericin B is this type of anti-fungal:
polyene
what is the MOA of amphotericin B?
penetrate cell membrane –> bind to ergosterol –> create pores –> Disrupt membrane integrity –> increase osmotic fragility
What is the therapyutic index of Amphotericin B? What are some adverse effects at onset of infusion? Later onset?
therapeutic index: poor ~1.5-2x
onset at infusion: Chills, fever, anemia, hypotension
later onset: nephrotoxicity –> direct damage to distal tubule membrane; Na, K, mg wasting, hypokalemia; Decreased GFR (arteriole constriction)
Amphotericin B aggravates the nephrotoxicity of other drugs, particularly these types of pts:
transplant, allograft pts: cyclosporine, sirolimus, tacrolimus
HIV pts: Foscarnet, pentamidine
Serious infx: Gram -, MRSA (Aminoglycosides, vancomycin)
What type of anti fungal drug is Fluconazole?
1st generation Triazole
what is the MOA of Azoles?
create deficit of ergosterol –> disrupt sterol content (create Lanosterol surplus, inhibit formation of ergosterol)
what are indications for Fluconazole?
Narrow spectrum
Candida albicans (candidemia, local candidiasis)
Cryptococcus (meningitis, with AMP-B)
what are limitations of Fluconazole?
NO activity vs Aspergillus
2nd line vs most true pathogens
What is the clearance of Fluconazole?
renal (75%)
what is the bioavailability and absorption of Itraconazole?
Poor bioavailability (50%) Poor solubility (requires acid)
what type of CSF access does Itraconazole have? Does it have any interaction with CYP450?
poor CSF access
Strong CYP450 inhibitor
This triazole is the drug of choice/recommended for Aspergillus spp
Voriconazole
This triazole is the drug of choice/recommended for histoplasmosis, coccidioides, and blastomycoses:
Itraconazole
this triazole is resistant to “other” candida and can be used for cryptococcus:
fluconzaole
list some fungal resistance mechanisms to azoles:
- mutation of lanosterol-14a-demethylase
- overexpression of lanosterol-14a-demethylase
- energy-dependent efflux systems
- changes in sterol and/or phospholipid composition of fungal cell membrane (decreased permeability)